Document:

EX-10.37

 Exhibit 10.37 

VANDA PHARMACEUTICALS INC. 

EMPLOYMENT AGREEMENT 

This Employment Agreement (this “Agreement”) is entered into as of June 12, 2009, by and between GUNTHER
BIRZNIEKS (the “Employee”) and VANDA PHARMACEUTICALS INC., a Delaware corporation (the “Company”). 

1. Duties and Scope of Employment. 

(a) Position. For the term of his employment under this Agreement (“Employment”), the Company agrees to employ the Employee
in the position of Vice President, Therapeutic Area. The Employee shall be subject to the supervision of, and shall have such authority as is delegated to him by, the Company’s Chief Executive Officer. The Employee hereby accepts such
employment and agrees to undertake the duties and responsibilities normally inherent in such position and such other duties and responsibilities as the Board shall from time to time reasonably assign to him. 

(b) Obligations to the Company. During the term of his Employment, the Employee shall devote his full business efforts and time to the
Company. During the term of his Employment, without the prior written approval of the Company’s board of directors (the “Board”), the Employee shall not render services in any capacity to any other person or entity and shall not act
as a sole proprietor or partner of any other person or entity or as a shareholder owning more than five percent of the stock of any other corporation. The Employee shall comply with the Company’s policies and rules, as they may be in effect
from time to time during the term of his Employment. 
 (c) No Conflicting Obligations. The Employee represents and warrants to the
Company that he is under no obligations or commitments, whether contractual or otherwise, that are inconsistent with his obligations under this Agreement. The Employee represents and warrants that he will not use or disclose, in connection with his
Employment, any trade secrets or other proprietary information or intellectual property in which the Employee or any other person has any right, title or interest and that his Employment as contemplated by this Agreement will not infringe or violate
the rights of any other person or entity. The Employee represents and warrants to the Company that he has returned all property and confidential information belonging to any prior employers. 

2. Cash and Incentive Compensation. 

(a) Salary. The Company shall pay the Employee as compensation for his services a base salary at a gross annual rate of not less than
$156,000. Such salary shall be payable in accordance with the Company’s standard payroll procedures. (The annual compensation specified in this Subsection (a), together with any increases in such compensation that the Company may grant from
time to time, is referred to in this Agreement as “Base Compensation.”) 

 (b) Incentive Bonuses. The Employee shall be eligible to be considered for an annual
incentive bonus with a target amount equal to 15% of his Base Compensation (the “Annual Target Bonus”). Such bonus (if any) shall be awarded based on objective or subjective criteria established in advance by the Board. The determinations
of the Board with respect to such bonus shall be final and binding. Any incentive bonus for a fiscal year shall in no event be paid later than 2 1⁄2 months
after the close of such fiscal year. Except as provided in Section 6, the Employee shall not be entitled to an incentive bonus if he is not employed by the Company on the date when such bonus is payable. 

3. Vacation and Employee Benefits. During the term of his Employment, the Employee shall be eligible for 20 paid vacation days each
year in accordance with the Company’s standard policy for similarly situated employees, as it may be amended from time to time. During the term of his Employment, the Employee shall be eligible to participate in any employee benefit plans
maintained by the Company for similarly situated employees, subject in each case to the generally applicable terms and conditions of the plan in question and to the determinations of any person or committee administering such plan. 

4. Business Expenses. During the term of his Employment, the Employee shall be authorized to incur necessary and reasonable travel,
entertainment and other business expenses in connection with his duties hereunder. The Company shall reimburse the Employee for such expenses upon presentation of an itemized account and appropriate supporting documentation, all in accordance with
the Company’s generally applicable policies. Any reimbursement shall (a) be paid promptly but not later than the last day of the calendar year following the year in which the expense was incurred, (b) not be affected by any other
expenses that are eligible for reimbursement in any calendar year and (c) not be subject to liquidation or exchange for another benefit. 

5. Term of Employment. 

(a) Basic Rule. The Company agrees to continue the Employee’s Employment, and the Employee agrees to remain in Employment with
the Company, from the date of this Agreement until the date when the Employee’s Employment terminates pursuant to Subsection (b) or (c) below. The Employee’s Employment with the Company shall be “at will,” meaning that
either the Employee or the Company may terminate the Employee’s Employment at any time, with or without Cause. Any contrary representations which may have been made to the Employee shall be superseded by this Agreement. This Agreement shall
constitute the full and complete agreement between the Employee and the Company on the “at will” nature of the Employee’s Employment, which may only be changed in an express written agreement signed by the Employee and a duly
authorized officer of the Company (other than the Employee). 
 (b) Termination. The Company may terminate the Employee’s
Employment at any time and for any reason (or no reason), and with or without Cause, by giving the Employee notice in writing. The Employee may terminate his Employment by giving the Company 14 days’ advance notice in writing. The
Employee’s Employment shall terminate automatically in the event of his death. 

  
 2 

 (c) Permanent Disability. The Company may terminate the Employee’s Employment due to
Permanent Disability by giving the Employee 30 days’ advance notice in writing. In the event that the Employee satisfactorily resumes the performance of substantially all of his duties hereunder before the termination of his Employment under
this Subsection (c) becomes effective, the notice of termination shall automatically be deemed to have been revoked. 
 (d) Rights
Upon Termination. Except as expressly provided in Section 6, upon the termination of the Employee’s Employment pursuant to this Section 5, the Employee shall only be entitled to the compensation, benefits and reimbursements
described in Sections 2, 3 and 4 for the period preceding the effective date of the termination. The payments under this Agreement shall fully discharge all responsibilities of the Company to the Employee. 

(e) Termination of Agreement. This Agreement shall terminate when all obligations of the parties hereunder have been satisfied. The
termination of this Agreement shall not limit or otherwise affect any of the Employee’s obligations under Section 7. 
 6.
Termination Benefits. 
 (a) General Release. Any other provision of this Agreement notwithstanding, Subsections (b), (c) and
(d) below shall not apply unless the Employee has executed a general release of all claims that he may then have against the Company or persons affiliated with the Company. The release shall be in a form prescribed by the Company, without
alterations. The Employee shall execute and return the release on or before the date specified by the Company in the prescribed form (the “Release Deadline”). The Release Deadline shall in no event be later than 60 days after the
Employee’s Separation. If the Employee fails to return the release on or before the Release Deadline, or if the Employee revokes the release, then the Employee shall not be entitled to the benefits described in this Section 6. 

(b) Severance Pay. If, during the term of this Agreement, a Separation occurs because the Company terminates the Employee’s
Employment for any reason other than Cause or Permanent Disability, or because the Employee terminates his Employment within six months after a condition constituting Good Reason arises, then the Company shall pay the Employee both of the following:

 (i) Base Compensation. His Base Compensation for a period of six months following the Separation (the
“Continuation Period”). Such Base Compensation shall be paid at the rate in effect at the time of the Separation and in accordance with the Company’s standard payroll procedures. The salary continuation payments shall commence within
30 days after the Release Deadline and, once they commence, shall be retroactive to the date of the Employee’s Separation. 

(ii) Target Bonus. A bonus in an amount equal to a pro-rata portion of the
Annual Target Bonus for the year during which the Separation occurs. Such amount shall be payable in a lump sum within 30 days after the Release Deadline. 

  
 3 

 (c) Health Insurance. If Subsection (b) above applies, and if the Employee
elects to continue his health insurance coverage under the Consolidated Omnibus Budget Reconciliation Act (“COBRA”) following the Separation, then the Company shall pay the Employee’s monthly premium under COBRA until the earliest of
(i)the close of the Continuation Period, (ii) the expiration of the Employee’s continuation coverage under COBRA and (iii) the date when the Employee is offered substantially equivalent health insurance coverage in connection with new
employment or self-employment. 
 (d) Options. If, during the term of this Agreement, a Separation occurs because the Company
terminates the Employee’s Employment for any reason other than Cause or Permanent Disability, then (i) the vested portion of the shares of the Company’s Common Stock subject to all options held by the Employee at the time of his
Separation shall be determined by adding three months to the actual period of service that he has completed with the Company and (ii) such options shall be exercisable for six months after the Employee’s Separation. 

7. Non-Solicitation, Non-Disclosure
and Non-Competition. The Employee has entered into a Proprietary Information and Inventions Agreement with the Company, which agreement is incorporated
herein by reference. 
 8. Successors. 

(a) Company’s Successors. This Agreement shall be binding upon any successor (whether direct or indirect and whether by
purchase, lease, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company’s business and/or assets. For all purposes under this Agreement, the term “Company” shall include any successor to the
Company’s business and/or assets which becomes bound by this Agreement. 
 (b) Employee’s Successors. This
Agreement and all rights of the Employee hereunder shall inure to the benefit of, and be enforceable by, the Employee’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees. 

9. Definitions. For all purposes under this Agreement, the following terms shall have the meaning set forth below: 

“Cause” shall mean: 

(a) An unauthorized use or disclosure by the Employee of the Company’s confidential information or trade secrets, which use or disclosure
causes material harm to the Company; 
 (b) A material breach by the Employee of any agreement between the Employee and the Company; 

  
 4 

 (c) A material failure by the Employee to comply with the Company’s written policies or
rules; 
 (d) The Employee’s conviction of, or plea of “guilty” or “no contest” to, a felony under the laws of the
United States or any State thereof; 
 (e) The Employee’s gross negligence or willful misconduct; 

(f) A continuing failure by the Employee to perform assigned duties after receiving written notification of such failure from the Board; or

 (g) A failure by the Employee to cooperate in good faith with a governmental or internal investigation of the Company or its directors,
officers or employees, if the Company has requested the Employee’s cooperation. 
 “Good Reason” shall mean
(i) the Employee’s receipt of notice that his principal workplace will be relocated by more than 30 miles or (ii) a reduction in the Employee’s Base Compensation by more than 10%, unless pursuant to a Company-wide reduction
affecting all employees proportionately. A condition shall not be considered “Good Reason” unless the Employee gives the Company written notice of such condition within 90 days after such condition comes into existence and the Company
fails to remedy such condition within 30 days after receiving the Employee’s written notice. 
 “Permanent Disability”
shall mean that the Employee, at the time notice is given, has failed to perform his duties under this Agreement for a period of not less than 90 consecutive days as the result of his incapacity due to physical or mental injury, disability or
illness. 
 “Separation” shall mean a “separation from service,” as defined in the regulations under
Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”). 
 10. Miscellaneous Provisions. 

(a) Notice. Notices and all other communications contemplated by this Agreement shall be in writing and shall be deemed to have
been duly given when personally delivered or when mailed by overnight courier, U.S. registered or certified mail, return receipt requested and postage prepaid. In the case of the Employee, mailed notices shall be addressed to him at the home address
that he most recently communicated to the Company in writing. In the case of the Company, mailed notices shall be addressed to its corporate headquarters, and all notices shall be directed to the attention of its Secretary. 

(b) Modifications and Waivers. No provision of this Agreement shall be modified, waived or discharged unless the modification,
waiver or discharge is agreed to in writing and signed by the Employee and by an authorized officer of the Company (other than the Employee). No waiver by either party of any breach of, or of compliance with, any condition or provision of this
Agreement by the other party shall be considered a waiver of any other condition or provision or of the same condition or provision at another time. 

  
 5 

 (c) Whole Agreement. No other agreements, representations or understandings
(whether oral or written and whether express or implied) which are not expressly set forth in this Agreement have been made or entered into by either party with respect to the subject matter hereof. This Agreement and the Proprietary Information and
Inventions Agreement contain the entire understanding of the parties with respect to the subject matter hereof. The letter agreement dated December 17, 2008, between the Employee and the Company is hereby superseded. 

(d) Tax Matters. All payments made under this Agreement shall be subject to reduction to reflect taxes or other charges
required to be withheld by law. For purposes of Section 409A of the Code, each periodic salary continuation payment under Section 6(b)(i) is hereby designated as a separate payment. If the Company determines that the Employee is a
“specified employee” within the meaning of Section 409A(a)(2)(B)(i) of the Code and the regulations thereunder at the time of his Separation, then: 

(i) Any salary continuation payments under Section 6(b)(i), to the extent not exempt from Section 409A of the Code,
shall commence during the seventh month after the Employee’s Separation and the installments that otherwise would have been paid during the first six months following the Employee’s Separation shall be paid in a lump sum when such salary
continuation payments commence; and 
 (ii) Any lump sum payment under Section 6(b)(ii), to the extent not exempt from
Section 409A of the Code, shall be made during the seventh month after the Employee’s Separation. 
 The Company shall not have a duty to design
its compensation policies in a manner that minimizes the Employee’s tax liabilities, and the Employee shall not make any claim against the Company or the Board related to tax liabilities arising from the Employee’s compensation. 

(e) Choice of Law. The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the
State of Maryland (except their provisions governing the choice of law). 
 (f) Severability. The invalidity or unenforceability of
any provision or provisions of this Agreement shall not affect the validity or enforceability of any other provision hereof, which shall remain in full force and effect. 

(g) Arbitration. Any controversy or claim arising out of or relating to this Agreement or the breach thereof, or the
Employee’s Employment or the termination thereof, shall be settled in the State of Maryland, by arbitration in accordance with the National Rules for the Resolution of Employment Disputes of the American Arbitration Association. The decision of
the arbitrator shall be final and binding on the parties, and judgment on the award rendered by the arbitrator may be entered in any court having jurisdiction thereof. The parties hereby agree that the arbitrator shall be empowered to enter an
equitable decree mandating specific enforcement of the terms of this Agreement. The Company and the Employee shall share equally 

  
 6 

 
all fees and expenses of the arbitrator. The Employee hereby consents to personal jurisdiction of the state and federal courts located in the State of Maryland for any action or proceeding
arising from or relating to this Agreement or relating to any arbitration in which the parties are participants. 
 (h) No Assignment.
This Agreement and all rights and obligations of the Employee hereunder are personal to the Employee and may not be transferred or assigned by the Employee at any time. The Company may assign its rights under this Agreement to any entity that
assumes the Company’s obligations hereunder in connection with any sale or transfer of all or a substantial portion of the Company’s assets to such entity. 

(i) Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of
which together shall constitute one and the same instrument. 
 [REMAINDER OF PAGE LEFT BLANK INTENTIONALLY] 

  
 7 

 IN WITNESS WHEREOF, each of the parties has executed this Agreement, in the case of the
Company by its duly authorized officer, as of the date first written above. 
  

	
	/s/ Gunther Birznieks
	Gunther Birznieks

  

			
	VANDA PHARMACEUTICALS INC.
		
	By	 	/s/ Mihael H. Polymeropoulos, M.D.
	Title:	 	President/CEO

  
 8Exhibit

Exhibit 10.36

HUNTINGTON INGALLS INDUSTRIES, INC.

AMENDED AND RESTATED DIRECTORS' COMPENSATION POLICY

Directors of Huntington Ingalls Industries, Inc., a Delaware corporation (the "Company"), who are not
employed by the Company or one of its subsidiaries (''non-employee directors") are entitled to the compensation set forth below for their service as a member of the Board of Directors (the "Board") of the Company. The Board has
the right to amend this policy from time to time.

	
			
	Cash Compensation
	 
	 

	Annual Retainer
	 
	$100,000

	Additional Non-Executive Chairman Retainer
	 
	$250,000

	Additional Committee Chair Retainers
	 
	 

	Audit Committee Chair
	 
	$20,000

	Compensation Committee Chair
	 
	$15,000

	Governance and Policy Committee Chair
	 
	$15,000

	Finance Committee Chair
	 
	$15,000

	Additional Audit Committee Member Retainer
	 
	$15,000

	Additional Compensation Committee Member Retainer
	 
	$5,000

	Additional Governance and Policy Committee Member Retainer
	 
	$5,000

	Additional Finance Committee Member Retainer
	 
	$5,000

	 
	 
	 

	Equity Compensation
	 
	 

	Annual Equity Award
	 
	$100,000

Cash Compensation

Each non-employee director will be entitled to an annual cash retainer while serving on the Board in the amount set forth above (the "Annual Retainer"). A non-employee director who serves as the Non-Executive Chairman of the Board will be entitled to an additional annual cash retainer while serving in that position in the amount set forth above (the "Additional Chair Retainer"). A non-employee director who serves as the Chairman of the Audit Committee, the Compensation Committee, the Governance and Policy Committee or the Finance Committee of the Board will be entitled to an additional annual cash retainer while serving in that position in the applicable amount set forth above (an "Additional Committee Chair Retainer''). A non-employee director who serves as a member of the Audit Committee, the Compensation Committee, the Governance and Policy Committee or the Finance Committee of the Board (other than as the Chairman of the applicable committee) will be entitled to an additional cash retainer while serving as a member of that committee in the applicable amount set forth above (the "Additional Committee Member retainer").  

The amounts of the Annual Retainer, Additional Chair Retainer, Additional Committee Chair Retainers and Additional Committee Member Retainers reflected above are expressed as annualized amounts. These retainers will be paid on a quarterly basis, at the end of each quarter in arrears. The retainer for a non-employee director for a particular quarter will be pro-rated if the non-employee director serves (or serves in the corresponding position, as the case may be) for only a portion of the quarter (with the proration based on the number of calendar days in the quarter that the director served as a non-employee director or held the particular position, as the case may be).  

Equity Awards 

On the first trading day of each fiscal quarter of the Company, each non-employee director then in office will automatically be granted an award of stock units determined by dividing (1) one-quarter (1/4) of the Annual Equity 

Award grant value set forth above by (2) the per-share closing price (in regular trading) of the Company's common stock on the New York Stock Exchange on the date of grant, rounded down to the nearest whole unit.  

Each stock unit award will be made under and subject to the terms and conditions of the Company’s 2012 Long-Term Incentive Plan or any successor equity compensation plan approved by the Company's stockholders and in effect at the time of grant (the “Plan”), and will be evidenced by, and subject to the terms and conditions of, an award certificate in the form approved by the Board to evidence such type of grant pursuant to this policy. Each award will be fully vested at grant and will generally become payable within 30 days following the date the non-employee director ceases to provide services as a member of the Board. Non-employee directors are entitled to receive dividend equivalents with respect to outstanding and unpaid stock units granted pursuant to this policy. Dividend equivalents, if any, are paid in the form of a credit of additional stock units under the Plan and are subject to the same vesting, payment and other provisions as the underlying stock units.  

Notwithstanding the foregoing, if a non-employee director beneficially owns shares of the Company’s common stock (his “Beneficial Ownership”) with a value equal to at least five times (5x) the director’s annual cash retainer (the “Ownership Guideline”) as of the date of the last quarterly grant of the Annual Equity Award for a given year (the “Measurement Date”), the non-employee director may elect under the terms of the Board Deferred Compensation Policy to receive his Annual Equity Award for the following calendar year in the form of either (a) shares of the Company’s common stock (with the number of shares being equal to the number of stock units the director would have been granted on each quarterly grant date, but for the election) or (b) stock units that are payable in the fifth calendar year after the year in which the Annual Equity Award is earned (or upon the director’s separation from service from the Board, if earlier).  The common stock or stock units, as the case may be, will be fully vested on the date of grant and will be issued under (and subject to the terms of) the Plan and the stock units will further be subject to the terms of the Board Deferred Compensation Policy. If the non-employee director elects to receive common stock and the non-employee director’s Beneficial Ownership is less than the Ownership Guideline as of any quarterly grant date in the following calendar year, the non-employee director will be required to retain all of the common stock received on that quarterly grant date (net of taxes) until the next Measurement Date on which his Beneficial Ownership is greater than the Ownership Guideline.

Any stock units credited to a non-employee director (including in an account under the Board Deferred Compensation Policy), any shares owned by a non-employee director, the non-employee director’s spouse or minor children, any shares owned by a trust for the benefit of a non-employee director or his or her family shall count as shares beneficially owned by a non-employee director for purposes of the Ownership Guideline. 

The foregoing general provisions are, in the case of a particular award, subject to the terms and conditions of the applicable award certificate.  

Expense Reimbursement

All non-employee directors will be entitled to reimbursement from the Company for their reasonable travel (including airfare and ground transportation), lodging and meal expenses incident to meetings of the Board or committees thereof or in connection with other Board-related business.  

Such benefits and reimbursements are not subject to liquidation or exchange for another benefit and the amount of such benefits and reimbursements that the non-employee director receives in one taxable year shall not affect the amount of such benefits or reimbursements that the non-employee director receives in any other taxable year. The non-employee director shall promptly provide the Company with reasonable written substantiation for any such expenses. The Company shall pay any such reimbursement to the non-employee director promptly after its receipt of such documentation and in all events not later than the end of the calendar year following the year in which the related expense was incurred.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00279-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00279-of-00352.parquet"}]]